Skip to main content
OpenTrials
Completed

NCT Number: NCT01980862

Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes

Single-site blood collection investigation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

To Measure Galectin-3 in Heart Failure Patients on Commercial Platforms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Maryland School of Medicine

Baltimore, Maryland, 21201, United States

About this study

45 Heart Failure patients will be recruited. Patients will provide a one-time blood sample specimen collection. Theses samples will be de-identified and provided for measurement of Galectin-3 on commercial platforms.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Heart Failure patients New York Heart Association class able to provide (4) collection tube types Subjects > 18 years old All subjects must provide informed consent and associated documentation

Exclusion criteria

  • Subjects that cannot tolerate blood withdrawal of 4 specimens collection tube tubes (approximately 40 mLs)

Treatment and study plan

Primary outcomes

  1. Obtain 45 matched donor serum and plasma samples sets collected from Heart Failure patients for galectin-3 measurements

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Fujirebio Diagnostics, Inc.

Industry

Registry information

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Nov 11, 2013
Registry last updated
Aug 5, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.